Kerala Ayurveda Ltd

Kerala Ayurveda Ltd

$KERALAYURPharmaceuticalsBSE

Kerala Ayurveda Ltd (KERALAYUR) last traded at ₹185, a market capitalisation of ₹241 crore. Over the past 52 weeks the stock has ranged between ₹145 and ₹507. Kerala Ayurveda Ltd last reported results for the quarter ended Jun 2026, with sales of ₹33.19 crore and net profit of ₹-8.08 crore. Kerala Ayurveda Ltd’s annual general meeting is scheduled for 28 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Kerala Ayurveda Ltd share price and key metrics

Current price
₹185
Market cap
₹241 cr
Book value
₹8.56
ROE
-161%
ROCE
-9.77%
Dividend yield
0.00%
52w high / low
507/145

Metrics as of 25 Aug 2026. Not real time.

Kerala Ayurveda Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹33.19 cr, up 16.0% from ₹28.61 cr a year earlier. Net profit swung to a loss of ₹8.08 cr.

Kerala Ayurveda Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales30.4131.1331.3228.6134.8432.9634.7433.19
Expenses24.8832.3241.4632.839.7934.4741.8437.02
Operating profit5.53-1.19-10.14-4.19-4.95-1.51-7.1-3.83
OPM %18.18%-3.82%-32.38%-14.65%-14.21%-4.58%-20.44%-11.54%
Other income0.640.230.739.471.71.131.910.26
Interest0.720.432.480.822.582.841.12.79
Depreciation1.980.721.921.650.991.151.691.87
Profit before tax3.47-2.11-13.812.81-6.82-4.37-7.98-8.23
Tax %-4.90%27.96%11.30%27.76%-6.74%5.26%-7.39%-1.82%
Net profit3.65-2.7-15.382.03-6.36-4.6-7.39-8.08
EPS (₹)2.84-2.40-12.921.65-5.26-3.69-5.97-6.14

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Kerala Ayurveda Ltd annual results

Kerala Ayurveda Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales628093108126131136
Operating profit11039-5-18-17
OPM %1.4%12%2.8%8%-4.0%-14%-13%
Net profit-52-0-1-14-16-26
EPS (₹)-4.592.24-0.85-0.47-11.60-12.74-21.06

TTM is the trailing twelve months to the most recent quarter.

Kerala Ayurveda Ltd growth and returns

Compounded Sales Growth
10 Years
11%
5 Years
16%
3 Years
12%
TTM
12%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
%
TTM
-104%
Stock Price CAGR
10 Years
11%
5 Years
20%
3 Years
16%
1 Year
-61%
Return on Equity
10 Years
-36%
5 Years
-69%
3 Years
-85%
Last Year
-161%

Kerala Ayurveda Ltd shareholding pattern

Promoters held 35.60% at Jun 2026, down from 37.83% at Jun 2025. FIIs 0.17% and DIIs 0.03%.

Kerala Ayurveda Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters58.58%58.58%58.58%37.83%33.14%33.14%35.60%35.60%
FIIs0.00%0.00%0.00%0.00%0.00%0.22%0.17%0.17%
DIIs0.03%0.03%0.03%0.03%0.03%0.03%0.03%0.03%
Public41.38%41.37%41.37%62.12%66.81%66.59%64.20%64.18%
No. of shareholders9,0529,0099,0749,4019,9389,95210,22510,372

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Kerala Ayurveda Ltd’s AGM?

Kerala Ayurveda Ltd’s annual general meeting is scheduled for 28 Sept 2026.

  • AGMAnnual General Meeting including re-appointment of Director

See the full results calendar for every Indian company reporting in the next 30 days.

Kerala Ayurveda Ltd corporate filings

  • Announcement under Regulation 30 (LODR)-Newspaper PublicationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Kerala Ayurveda Ltd has fulfilled its regulatory obligation under Regulation 30 of the…

    Read the full analysis
  • Announcement under Regulation 30(LODR)- Press ReleaseCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Kerala Ayurveda Ltd has submitted a press release under Regulation 30 of the SEBI (LODR)…

    Read the full analysis
  • Announcement under Regulation 30 (LODR) - Allotment of ESOPCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Kerala Ayurveda Ltd has formally announced the allotment of equity shares pursuant to the…

    Read the full analysis
  • Outcome of Board 12th August 2026Board Meetingmedium impact
    Filing PDF

    Cruxal's analysis: Kerala Ayurveda Limited reported a net loss of 7.67 crore for the quarter ended June 30…

    Read the full analysis
  • Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the unaudited financial results ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Kerala Ayurveda Limited has issued a formal intimation regarding a Board of Directors…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Kerala Ayurveda Ltd

Cruxal reads every Kerala Ayurveda Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.